Our previous study showed that the commercially available ovarian cancer cell lines ES-2 and OAW-42 expressed the markers characteristic for the mesenchymal stem cell markers CD73 (ecto-5′-nucleotidase), CD90 (Thy-1), and CD105 (endoglin) [31]. The gene discussed is THY1; the disease is ovarian carcinoma.